Sustained response of recombinant human C1 esterase inhibitor for acute treatment of hereditary angioedema attacks.

[1]  J. Bernstein,et al.  Expert perspectives on hereditary angioedema: Key areas for advancements in care across the patient journey , 2016, Allergy & rhinology.

[2]  W. Lumry,et al.  Icatibant for Multiple Hereditary Angioedema Attacks across the Controlled and Open-Label Extension Phases of FAST-3 , 2015, International Archives of Allergy and Immunology.

[3]  J. Bernstein,et al.  Recombinant replacement therapy for hereditary angioedema due to C1 inhibitor deficiency. , 2015, Immunotherapy.

[4]  J. Bernstein,et al.  Recombinant human-C1 inhibitor is effective and safe for repeat hereditary angioedema attacks. , 2015, The journal of allergy and clinical immunology. In practice.

[5]  J. Bernstein,et al.  Current state of hereditary angioedema management: a patient survey. , 2015, Allergy and asthma proceedings.

[6]  R. Lockey,et al.  [WAO Guideline for the Management of Hereditary Angioedema]. , 2015, Arerugi = [Allergy].

[7]  W. Lumry,et al.  Repeat treatment of acute hereditary angioedema attacks with open‐label icatibant in the FAST‐1 trial , 2014, Clinical and experimental immunology.

[8]  J. Bernstein,et al.  Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial. , 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[9]  J. Bernstein,et al.  US Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiency. , 2013, The journal of allergy and clinical immunology. In practice.

[10]  J. Sheikh,et al.  A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema. , 2013, The Journal of allergy and clinical immunology.

[11]  T. Machnig,et al.  Treatment with C1-esterase inhibitor concentrate in type I or II hereditary angioedema: a systematic literature review. , 2013, Allergy and asthma proceedings.

[12]  R. Lockey,et al.  Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study. , 2013, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[13]  K. Obtulowicz,et al.  Recombinant human C1 inhibitor for the prophylaxis of hereditary angioedema attacks: a pilot study , 2013, Allergy.

[14]  J. Bernstein,et al.  Assessment of rebound and relapse following ecallantide treatment for acute attacks of hereditary angioedema , 2012, Allergy.

[15]  T. Caballero.  Efficacy Assessments in Randomized Controlled Studies of Acute Therapy for Hereditary Angioedema , 2012, Journal of Clinical Immunology.

[16]  J. Stockman.  Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema , 2012 .

[17]  C. Town,et al.  Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial. , 2011, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[18]  J. Nuijens,et al.  Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema. , 2010, The Journal of allergy and clinical immunology.

[19]  A. Sheffer,et al.  Ecallantide for the treatment of acute attacks in hereditary angioedema. , 2010, The New England journal of medicine.

[20]  William H. Yang,et al.  Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. , 2010, The New England journal of medicine.

[21]  B. Zuraw.  Clinical practice. Hereditary angioedema. , 2008, The New England journal of medicine.

[22]  K. Bork,et al.  Asphyxiation by laryngeal edema in patients with hereditary angioedema. , 2000, Mayo Clinic proceedings.

[23]  M. Cicardi,et al.  C1-inhibitor concentrate for treatment of hereditary angioedema. , 1980, The New England journal of medicine.